National Cancer Institute (NCI) Symposium: BRD4, a Central Player in Cancer and Immune Responses

15 May 2017
10:15 AM – 12:15 PM
Room 207A

National Cancer Institute (NCI) Symposium: BRD4, a Central Player in Cancer and Immune Responses

Chairs:
Devaiah Ballachanda, NCI, NIH
T. Kevin Howcroft, NCI, NIH

Speakers:

  • Dinah S. Singer, NCI, NIH, BRD4, linking chromatin structure and transcription
  • Cheng-Ming Chiang, Univ. of Texas Southwestern Med. Ctr., BRD4 in gene-specific targeting and cancer therapeutics
  • Rugang Zhang, Wistar Inst., BRD4 and antitumor immunity in ovarian cancer
  • Gerald V. Denis, Boston Univ. Sch. of Med., BET bromodomain proteins couple microenvironment cytokines to breast cancer progression